溴化异丙托品、特布他林、布地奈德联合气雾吸入治疗婴幼儿喘息性疾病临床观察  

Therapeutic evaluation of triad nebulization with ipratropium bromide and terbutaline and budesonide to treat asthmatic disease in infant and preschool children

作　　者：赵红[1] 

机构地区：[1]天津医科大学总医院,天津300052

出　　处：《天津药学》2003年第6期21-23,共3页Tianjin Pharmacy

摘　　要：目的 :观察溴化异丙托品、特布他林、布地奈德联合气雾吸入治疗婴幼儿喘息性疾病的疗效。方法 :将 5 8例患儿随机分为两组。在综合治疗的基础上 ,观察组给予溴化异丙托品、特布他林、布地奈德联合气雾吸入治疗 ,对照组静脉滴注地塞米松和氨茶碱 ,观察两组疗效及临床症状、体征持续时间。结果 :观察组的咳嗽、喘憋及肺部哮鸣音、湿罗音消失天数均小于对照组。结论 :溴化异丙托品、特布他林、布地奈德联合气雾吸入治疗婴幼儿喘息性疾病具有协同作用 ,起效快 ,副作用少 ,可缩短病程 。Object: To observe the effect of triad nebulization with ipratropium bromide, terbutaline and budesonide in treating asthmatic disease in infant and preschool children. Methods: 58 cases with asthmatic disease were randomizely divided into 2 groups. On the basis of comprehensive therapy, the treatment group was treated with triad nebulization with ipratropium bromide, terbutaline and budesonide; the control group intravenous infusion of dexamethasone and aminophyline. The efficacy and the improvement of symptoms and signs of two groups were observed after treatment. Results: The improvement of symptoms and signs were significant in treatment group than that in control group. Conclusion: Triad nebulization with ipratropium bromide, terbutaline and budesonide to treat asthmatic disease in infant and preschool children could take effect rapidly and had fewer side effects. It can short disease term and increase the recovery rates.

关 键 词：喘息性疾病 溴化异丙托品 特布他林 布地奈德 气雾吸入 治疗 婴幼儿 医学 

分 类 号：R974.3[医药卫生—药品]